DK0812206T3 - Fremgangsmåde til stimulering af en immunrespons - Google Patents

Fremgangsmåde til stimulering af en immunrespons

Info

Publication number: DK0812206T3
Authority: DK; Denmark
Prior art keywords: immune response; stimulating; individuals; pathogenic; ligand
Prior art date: 1995-03-01

Application number

DK96909555T

Other languages

English (en)

Inventor

Charles R Maliszewski

Mark Alderson

Kim A Campbell

Mary K Kennedy

Original Assignee

Immunex Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-03-01

Filing date

1996-02-29

Publication date

2002-09-09

1996-02-29 Application filed by Immunex Corp filed Critical Immunex Corp

2002-09-09 Application granted granted Critical

2002-09-09 Publication of DK0812206T3 publication Critical patent/DK0812206T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2878—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Organic Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Cell Biology (AREA)
Tropical Medicine & Parasitology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Biochemistry (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Steroid Compounds (AREA)
Medicines Containing Plant Substances (AREA)
Oscillators With Electromechanical Resonators (AREA)
Electrotherapy Devices (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

DK96909555T 1995-03-01 1996-02-29 Fremgangsmåde til stimulering af en immunrespons DK0812206T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US39623095A	1995-03-01	1995-03-01
PCT/US1996/002839 WO1996026735A1 (en)	1995-03-01	1996-02-29	Method for stimulating an immune response

Publications (1)

Publication Number	Publication Date
DK0812206T3 true DK0812206T3 (da)	2002-09-09

Family

ID=23566398

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK96909555T DK0812206T3 (da)	1995-03-01	1996-02-29	Fremgangsmåde til stimulering af en immunrespons

Country Status (15)

Country	Link
EP (1)	EP0812206B1 (da)
JP (1)	JP3657271B2 (da)
KR (1)	KR19980702490A (da)
AT (1)	ATE220331T1 (da)
AU (1)	AU699291B2 (da)
CA (1)	CA2213798C (da)
DE (1)	DE69622259T2 (da)
DK (1)	DK0812206T3 (da)
ES (1)	ES2179187T3 (da)
FI (1)	FI973484A7 (da)
MX (1)	MX9706588A (da)
NO (1)	NO973875L (da)
NZ (1)	NZ305083A (da)
PT (1)	PT812206E (da)
WO (1)	WO1996026735A1 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1999022008A1 (fr) *	1997-10-27	1999-05-06	Sumitomo Electric Industries, Ltd.	Inducteur pour la production d'un anticorps specifique de l'antigene, vecteur d'expression contenant le gene requis a cette fin, et procede pour induire la production de l'anticorps specifique de l'antigene
WO1999032138A1 (en) *	1997-12-19	1999-07-01	Immunex Corporation	Method for reducing susceptibility to hiv infection
DK1616579T3 (da) *	1998-05-23	2009-09-14	Univ Leiden Medical Ct	CD40 bindende molekyler og CTL peptider til behandling af tumorer
US7371392B2 (en)	2000-02-02	2008-05-13	The United States Of America As Represented By The Department Of Health And Human Services	Cd40 ligand adjuvant for respiratory syncytial virus
MY188753A (en)	2006-09-18	2021-12-29	Univ Arkansas	Compositions and methods of enhancing immune responses
AU2008318615A1 (en)	2007-10-30	2009-05-07	Texas A&M University System	Compositions and methods of enhancing immune responses to flagellated bacterium
ES2761693T3 (es)	2007-11-01	2020-05-20	Univ Arkansas	Composiciones y métodos para mejorar las respuestas inmunitarias a Eimeria
JP6242050B2 (ja)	2010-01-21	2017-12-06	ザボードオブトラスティーズオブザユニバーシティオブアーカンソー	免疫応答を増強するワクチンベクターおよび方法
CN102971008B (zh)	2010-06-09	2015-11-25	阿肯色大学评议会	降低弯曲菌属感染的疫苗和方法
RU2609647C2 (ru)	2011-04-29	2017-02-02	Апексиджен, Инк.	Анти-cd40-антитела и способы применения
CN109265552A (zh)	2012-10-30	2019-01-25	埃派斯进有限公司	抗-cd40抗体及其使用方法
NZ711019A (en)	2013-02-14	2019-07-26	Univ Arkansas	Compositions and methods of enhancing immune responses to eimeria or limiting eimeria infection
WO2014152508A1 (en)	2013-03-15	2014-09-25	The Board Of Trustees Of The University Of Arkansas	Compositions and methods of enhancing immune responses to enteric pathogens
CN115887671A (zh)	2015-07-16	2023-04-04	百欧肯治疗有限公司	治疗癌症的组合物及方法
AU2017252527A1 (en)	2016-04-18	2018-11-08	Celldex Therapeutics, Inc.	Agonistic antibodies that bind human CD40 and uses thereof
JP7467027B2 (ja)	2016-05-03	2024-04-15	ザボードオブトラスティーズオブザユニバーシティオブアーカンソー	免疫刺激性ポリペプチドおよび抗原性ポリペプチドを含む酵母ワクチンベクター並びにそれを使用する方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2227513T5 (es) *	1991-10-25	2009-04-01	Immunex Corporation	Citoquina novedosa.
AU5098493A (en) *	1992-08-21	1994-03-15	Schering Corporation	Cd40 ligand, anti cd40 antibodies, and soluble cd40
ATE255906T1 (de) *	1993-10-01	2003-12-15	Immunex Corp	Antikörper gegen cd40

1996
- 1996-02-29 AU AU53011/96A patent/AU699291B2/en not_active Ceased
- 1996-02-29 ES ES96909555T patent/ES2179187T3/es not_active Expired - Lifetime
- 1996-02-29 CA CA002213798A patent/CA2213798C/en not_active Expired - Fee Related
- 1996-02-29 EP EP96909555A patent/EP0812206B1/en not_active Expired - Lifetime
- 1996-02-29 PT PT96909555T patent/PT812206E/pt unknown
- 1996-02-29 NZ NZ305083A patent/NZ305083A/xx not_active IP Right Cessation
- 1996-02-29 DK DK96909555T patent/DK0812206T3/da active
- 1996-02-29 DE DE69622259T patent/DE69622259T2/de not_active Expired - Lifetime
- 1996-02-29 MX MX9706588A patent/MX9706588A/es not_active IP Right Cessation
- 1996-02-29 WO PCT/US1996/002839 patent/WO1996026735A1/en active IP Right Grant
- 1996-02-29 AT AT96909555T patent/ATE220331T1/de not_active IP Right Cessation
- 1996-02-29 JP JP52643096A patent/JP3657271B2/ja not_active Expired - Fee Related
- 1996-02-29 KR KR1019970705890A patent/KR19980702490A/ko not_active Withdrawn
- 1996-02-29 FI FI973484A patent/FI973484A7/fi unknown
1997
- 1997-08-22 NO NO973875A patent/NO973875L/no unknown

Also Published As

Publication number	Publication date
DE69622259T2 (de)	2003-03-27
MX9706588A (es)	1997-11-29
CA2213798C (en)	2001-02-06
CA2213798A1 (en)	1996-09-06
EP0812206A1 (en)	1997-12-17
ATE220331T1 (de)	2002-07-15
FI973484L (fi)	1997-10-24
KR19980702490A (ko)	1998-07-15
ES2179187T3 (es)	2003-01-16
WO1996026735A1 (en)	1996-09-06
EP0812206B1 (en)	2002-07-10
DE69622259D1 (de)	2002-08-14
NO973875L (no)	1997-10-31
JP3657271B2 (ja)	2005-06-08
AU699291B2 (en)	1998-11-26
AU5301196A (en)	1996-09-18
NZ305083A (en)	1999-06-29
NO973875D0 (no)	1997-08-22
JPH11506418A (ja)	1999-06-08
PT812206E (pt)	2002-11-29
FI973484A0 (fi)	1997-08-25
FI973484A7 (fi)	1997-10-24

Publication	Publication Date	Title
DK0724456T3 (da)	2004-04-13	CD40-Antistoffer
DK0812206T3 (da)	2002-09-09	Fremgangsmåde til stimulering af en immunrespons
MX9603080A (es)	1998-01-31	Anticuerpos monoclonales inmuno-estimulantes.
DE69221147D1 (de)	1997-09-04	Nicht glycosylierter Anti-CD3-IgG-Antikörper
DE69316948D1 (de)	1998-03-19	Lösliche Liganden für CD40
DE69429925D1 (de)	2002-03-28	METHODE ZUR BINDUNG VON MATERIAL AN DAS Beta-AMYLOID-PEPTID
EP1266965A3 (en)	2003-01-02	Recombinant antibodies for human therapy
IL221708A0 (en)	2012-10-31	Polyclonal goat anti-hla class ii antibody for treatment of disease involving proliferative immune response
NO971059D0 (no)	1997-03-07	Modifiserte human-C3-proteiner
DK1167389T3 (da)	2007-11-12	Antistoffer mod SEMP1-proteinet, fremgangsmåde til fremstilling heraf samt anvendelse deraf
ATE206621T1 (de)	2001-10-15	Il-8 antagonisten zur behandlung von asthma
ATE309371T1 (de)	2005-11-15	Protein mit dnase-aktivität
DE69118702D1 (de)	1996-05-15	Neue verwendung eines monoklonalen antikörpers